{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:51:04Z","timestamp":1767149464884,"version":"build-2238731810"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.xkme.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T13:47:47Z","timestamp":1552571267000},"page":"75-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-4735","authenticated-orcid":false,"given":"Hisato","family":"Shima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimichi","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Minakuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.xkme.2019.03.001_bib1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1177\/1060028013504076","article-title":"Alogliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus","volume":"47","author":"Jarvis","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2019.03.001_bib2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12877-017-0571-8","article-title":"Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing","volume":"17","author":"Schott","year":"2017","journal-title":"BMC Geriatr"},{"issue":"3","key":"10.1016\/j.xkme.2019.03.001_bib3","first-page":"186","article-title":"Alogliptin (Nesina) for adults with type-2 diabetes","volume":"39","author":"Dineen","year":"2014","journal-title":"Pharm Ther"},{"issue":"suppl 6","key":"10.1016\/j.xkme.2019.03.001_bib4","first-page":"vi52","article-title":"Secondary minimal change disease","volume":"18","author":"Glassock","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2215\/CJN.01790506","article-title":"Granulomatous interstitial nephritis","volume":"2","author":"Joss","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ckj\/sfv053","article-title":"Granulomatous interstitial nephritis","volume":"8","author":"Shah","year":"2015","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1016\/j.xkme.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1471-4906(03)00142-X","article-title":"The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation","volume":"24","author":"Rajan","year":"2003","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.xkme.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12882-018-0854-0","article-title":"Cilostazol-induced acute tubulointerstitial nephritis accompanied by IgA nephropathy: a case report","volume":"19","author":"Shima","year":"2018","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2019.03.001_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2019.03.001_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfg464","article-title":"The changing profile of acute tubulointerstitial nephritis","volume":"19","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2019.03.001_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ckj\/sfv129","article-title":"The use of gallium-67 scintigraphy in the diagnosis of acute interstitial nephritis","volume":"9","author":"Graham","year":"2016","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.xkme.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.amjmed.2011.06.003","article-title":"Sarcoidosis: challenging diagnostic aspects of an old disease","volume":"125","author":"Spagnolo","year":"2012","journal-title":"Am J Med"},{"issue":"21","key":"10.1016\/j.xkme.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Teirstein, Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jctube.2017.02.001","article-title":"Histopathologic review of granulomatous inflammation","volume":"7","author":"Shah","year":"2017","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"issue":"9","key":"10.1016\/j.xkme.2019.03.001_bib15","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1681\/ASN.2006020139","article-title":"Multiple myeloma","volume":"17","author":"Korbet","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fimmu.2014.00549","article-title":"Eosinophilic granulomatosis with polyangiitis: an overview","volume":"5","author":"Gioffredi","year":"2014","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.xkme.2019.03.001_bib17","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2169\/internalmedicine.47.1457","article-title":"Alendronate-induced esophagitis: possible pathogenic role of hypersensitivity to alendronate","volume":"47","author":"Naniwa","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.xkme.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2957\/kanzo.48.517","article-title":"Recent status of drug-induced liver injury: an analysis of 366 cases between 2002 and 2006","volume":"48","author":"Takikawa","year":"2007","journal-title":"Kanzo"},{"issue":"12","key":"10.1016\/j.xkme.2019.03.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028096","article-title":"Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool","volume":"6","author":"Gallagher","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xkme.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fphar.2017.00835","article-title":"Renoprotective effect of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus","volume":"8","author":"Esaki","year":"2017","journal-title":"Front Pharmacol"}],"updated-by":[{"DOI":"10.1016\/j.xkme.2019.12.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000}}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059519300202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059519300202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:19:28Z","timestamp":1762910368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059519300202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2590059519300202"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2019.03.001","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}